The largest hair loss community and research database in the world
Learn
Read about the basics and view an index of important topics related to hair.Research
View the full text research archives for any subject related to hair loss and alopecia.Community
Connect with hundreds of thousands of others who are defeating hair loss.TresslessGPT
Ask the chat bot any questions about hair loss and treatments. Answers are based on the latest research and the opinions of the community. Now free for everyone.
Popular topics:
New in community
- Featured Community Post
Research Backed Dutasteride Simulator (Serum/scalp DHT included for all doses)
A Dutasteride Simulator predicts serum dutasteride, serum DHT, and scalp DHT levels using models from research papers. It simulates various dosing schedules to determine steady-state effects and visualizes outcomes, including hair growth-related scalp DHT suppression.
Read More -
I have been using Dutasteride 0.5 mg (Avodart) since June 2023
General The user has been using Dutasteride (Avodart) 0.5 mg since June 2023 to combat hair thinning, experiencing initial side effects but no significant hair regrowth. They seek advice on improving or thickening their hair further. -
M40 - 3 Months progress on Fin/Min
Is this regrowth? A user reported significant hair regrowth after 3 months using 1mg oral finasteride, 1ml 5% topical minoxidil, and microneedling, along with biotin, vitamin D, iron, and zinc supplements. They are optimistic about continued progress despite initial skepticism. -
Minoxidil and Dutasteride just under 3 months update so happy I think I managed to save my hair just in time I feel it really is crucial you start medication the second you notice the problem
Progress Pictures The user shared progress on hair regrowth using oral minoxidil and dutasteride over three months, expressing satisfaction with the results. The user emphasized the importance of starting treatment early upon noticing hair loss. -
3 months of topical minoxidil 5% and 1mg of oral finasteride
Is this regrowth? The user experienced significant hair regrowth after three months of using topical minoxidil 5% and 1mg oral finasteride, along with addressing vitamin D and iron deficiencies. Some users expressed skepticism about the rapid results, while others congratulated the user on their progress. -
Is this subtle improvement or are my eyes playing tricks on me?
Progress Pictures The user is experiencing noticeable hair improvement after 4.5 months of using a treatment regimen including minoxidil, finasteride, biotin, Nioxin shampoo, microneedling, topical NANoxidil, and copper peptides. Feedback from others is positive, encouraging the user to continue the treatment for at least a year or more. -
Happiness is just a gap between sheds
Progress Pictures A user shared their experience with hair loss treatments, switching from 1mg finasteride and topical minoxidil to 5mg oral minoxidil and oral dutasteride, noting improvements despite shedding phases. Other users discussed the hair growth cycle, treatment effects, and shared advice on managing hair loss, including buzzing hair and maintaining mental health.
New Featured Research
Ingredients of Trichological Shampoos with Alleged Beneficial Effects on Hair—What Is Really Known About Their Efficacy? A Scoping Review of an Area with More Unknowns than Knowns
This scoping review evaluated the efficacy of ingredients in trichological shampoos advertised as active against hair loss. Out of 112 ingredients identified, only 16 were tested in 29 clinical trials. Four ingredients—adenosine, caffeine, placental protein, and melatonin—were tested individually, with moderate to low evidence of efficacy. Twelve other ingredients were tested in complex formulations, making it difficult to attribute effects to specific components. No clinical trials were found for 20 ingredients frequently claimed to be active. Overall, the evidence supporting the efficacy of these shampoo ingredients is limited, highlighting significant gaps in the scientific validation of non-prescription hair loss treatments.
Read More
New in research
-
Comparative Histomorphometric and Transcriptomic Analysis Reveals Potential Genetic Determinants of Pelage Variation Between Hairy and Coarse-Woolly Sheep
Genetic differences in sheep affect wool type, with fat and immune genes influencing hair traits.
-
Redox-Modulatory and MET-Inhibitory Triad: Synergistic Cytotoxicity of L-Cysteine, NAC, and MET Inhibition in Cervical Cancer Cells
Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.
-
JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.
-
The Impact of Botulinum Toxin on Hair Transplantation Outcomes: A Split-Scalp Randomized Controlled Trial
Botulinum toxin may improve hair transplant success by enhancing graft survival and hair density.
-
Styling Nature: A Comprehensive Review and Experimental Evaluation of Polyherbal Hair Gels in Cosmetic Science
Natural hair gels with herbal extracts like Aloe vera and hibiscus are safer and effective for hair health.
-
From Tradition to Technology: A Review of Natural Hair Oils in Hair Care
Natural hair oils are beneficial for hair care, but future use must balance effectiveness, safety, and sustainability.
-
The Impact of Botulinum Toxin on Hair Transplantation Outcomes: A Split-Scalp Randomized Controlled Trial
Botulinum toxin may improve hair transplant success by enhancing graft survival and hair density.
-
Integrative Nutritional Mechanisms of Keyora Lycopene 23 in 1 Men's Multi-Vitamin in Erectile Dysfunction, Male Infertility, Prostatic Disorders, and Metabolic Dysregulation
Keyora Lycopene 23 in 1 Man's Multi-Vitamin improves male reproductive health and metabolism.
-
JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.